Skip to main content

#151789

Anti-BLK [BLK154/D4]

Cat. #151789

Anti-BLK [BLK154/D4]

Cat. #: 151789

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: BLK

Class: Monoclonal

Application: WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Jacqueline Cordell

Institute: University of Oxford

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-BLK [BLK154/D4]
  • Research fields: Apoptosis and autophagy
  • Clone: BLK154/D4
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: WB
  • Description: B lymphoid tyrosine kinase is a member of the src family of proto-oncogenes that are involved in cell proliferation and differentiation1. It is expressed in B cells during all stages of development and has a role in B-cell receptor signaling and B-cell development2,3. BLK also stimulates insulin synthesis and secretion in response to glucose by up regulating pancreatic beta-cell transcription factors.
  • Immunogen: Recombinant protein corresponding to amino acids 53- 224 of human BLK
  • Isotype: IgG1
  • Myeloma used: NS0
  • Recommended controls: Human B cell line

Target Details

  • Target: BLK
  • Tissue cell line specificity: Human B cell line
  • Target background: B lymphoid tyrosine kinase is a member of the src family of proto-oncogenes that are involved in cell proliferation and differentiation1. It is expressed in B cells during all stages of development and has a role in B-cell receptor signaling and B-cell development2,3. BLK also stimulates insulin synthesis and secretion in response to glucose by up regulating pancreatic beta-cell transcription factors.

Applications

  • Application: WB

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Borowiec et al. 2009. Proc Natl Acad Sci U S A. 106(34):14460-5. PMID: 19667185.
  • Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction.
  • Wasserman et al. 1995. J Immunol. 155(2):644-51. PMID: 7608542.
  • Differential expression of the blk and ret tyrosine kinases during B lineage development is dependent on Ig rearrangement.
  • Islam et al. 1995. J Immunol. 154(3):1265-72. PMID: 7822795.
  • Molecular cloning, characterization, and chromosomal localization of a human lymphoid tyrosine kinase related to murine Blk.
  • Yao et al. 1993. Proc Natl Acad Sci U S A. 90(17):7946-50. PMID: 7690139.
  • Antisense oligodeoxynucleotides to the blk tyrosine kinase prevent anti-mu-chain-mediated growth inhibition and apoptosis in a B-cell lymphoma.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.